Mastek Ltd Q2 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/l5nivsy53b5wbo1qfd55pjs3.pdf

Key Takeaways


Revenue & Backlog: The Deferred-Consumption Drag

Umang Nahata: "There is this trend of consolidating business into larger deals, and we are seeing a very healthy pipe of $100 million plus kinds of deals sitting in our pipeline, which will be adjudicated over the next six to nine months... that's another important factor which can change the order backlog in a single transaction itself. It can impact the numbers sizably."

Margin Walk: Wage Hit, Mix Shift, and the AI Offset

Deepak Kedia: "One factor which I said which basically has dropped the margin is the onsite mix wherein the ask for local security-cleared resources is definitely going up and localization is definitely going up. And we will have to deal with that and that will require a systematic change internally for us to basically recover that."

UK: Strong Revenue, Stalled Orders


North America: Muted H1, H2 Turnaround Bet


AI Strategy: High-Margin Transformation vs. Red-Ocean Productivity

Umang Nahata: "Hence, the focus is to move towards more and more transformation business, which is much sweeter in terms of Mastek’s capability than just compete on the AI productivity, which is clearly a red ocean."

Verticals & Geographies: BFSI Strong, Healthcare Timing Gap, Middle East Uncertain

Vertical / GeographyTrendCommentary
BFSI▲ StrongGrowth largely orchestrated by UK-Europe with modern data work; North America financial services seeing good openings and new logos but still early stages.
Healthcare & Life Sciences▼ SoftSoftness from UK-Europe; projects finished alpha phase and recontracting for beta took longer than anticipated, especially on the government side; also saw ramp-down in one traditional offshore account.
UK Financial Services▲ Grew 16%+Robust quarter driven by modern data deals including Bank of England and Financial Conduct Authority.
APAC & Middle East▼ UncertainUncertainty continues and is getting more stringent; decent Q2 bounce from old standing contracts being signed, but outlook remains uncertain, especially with the situation in Saudi Arabia.
Oracle business▲ HealthyNet-new traction in North America and UK & Europe; also winning AI-led managed services delivering productivity on Oracle.
Energy & Utilities▲ BuildingThree new frameworks landed; contracts starting to be won within them; management will report progress as the year goes forward.

People, Cash, and Operations


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growthH2 performance should continue to do well; FY27 will do better than FY26FY27 full year
North America growthMeaningful turnaround in growth momentumStarting H2 FY27
EBITDA margin recoveryImprove by at least 160 bps in the medium term; US and Middle East margin improvement starting Q3Medium term; Q3 for US/ME
Healthcare & Life Sciences recoveryBeta contracts awarded and ramp back up; vertical bounces back as one of strongest growth enginesQ3 to early Q4 FY27
UK public sector order bookingMomentum corrects as clarity emerges post budget announcementPost-UK budget (imminent)
AI revenue disclosureStart outlining and presenting AI revenue numbers; Data & AI horizontal lens on organizationStarting next quarter (Q3 FY27)
UK NHS large contractNorth of £10 crore deal bid for; would be addition to current TCVH2 FY27 event
Large deal pipeline$100M+ deals in UK-Europe and North America to be adjudicatedNext 6–9 months

Key Metrics

MetricQ2 FY27
Revenue$107.3 million, +2.4% QoQ in constant currency
Revenue (INR)₹1,018.7 crore, +3.4% QoQ and +8.3% YoY
Operating EBITDA margin14.4%, down 100 bps QoQ; increments and ESOPs had 190 bps impact, partially offset by AI-led efficiencies and additional working days
PAT₹105.7 crore, 10.3% of total income
Basic EPS₹34.1, up 8.3% YoY
Diluted EPS₹33.9, up 8.4% YoY
12-month order backlog$286.2 million, -7.7% QoQ and +2.3% YoY in USD; +10.4% YoY in INR
UK revenue growth4.1% QoQ
UK EBIT18%
North America total backlog growth+7.8% QoQ and +47.9% YoY
AI deals as a percentage of total order book~45% (53 AI orders closed in the quarter)
Public sector sequential growth6.1%
Financial Services sequential growth15.3%
DSO74 days, a decrease of 1 day
Closing cash and investments net of debt₹582.7 crore, after ₹50 crore dividend and ~₹55 crore loan repayment; net addition of ~₹36 crore during the quarter
Total headcount4,810, a reduction of 87
Last 12-month attrition15.2%, down from 16.4% (a 1.2% decline)
Utilization including traineesDown 0.8% sequentially
New customers added18, versus 13 in the previous quarter
Project business as a percentage of total revenues44%–45%, up from 40%
Subcon cost as a percentage of revenue~18%–20%, may move up or down by 1 ppt in the short term
Healthcare vertical decline over the last yearDown more than 25% (per an analyst's math)